Fenwick & West represented Twelve Labs in the transaction. Twelve Labs, a video understanding company that provides industry-leading video AI solutions, announced it raised $30 million...
You must be a Standard 1 Year member to access this content.
Fenwick & West is representing Smartsheet on the transaction, while Kirkland & Ellis and Simpson Thacher & Bartlett are representing Blackstone and Vista Equity Partners. Smartsheet...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Oleria in the transaction. Oleria announced it raised $33 million in a Series A funding round. This latest investment, which brings the company’s...
You must be a Standard 1 Year member to access this content.
Fenwick & West and Sidley Austin are representing Impel Pharmaceuticals Inc. in the transaction. JN BIDCO LLC announced the acquisition of Impel Pharmaceuticals Inc. (OTCQX: IMPL)....
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Pulumi in the transaction. Pulumi announced $41 million in Series C financing led by Madrona with participation from NEA, Tola Capital and Strike Capital. ...
You must be a Standard 1 Year member to access this content.
Fenwick represented Cadence Neuroscience on the deal. Cadence Neuroscience, a medical device company, announced that it has secured $26 million in Series B financing. The round was led by...
You must be a Standard 1 Year member to access this content.
Fenwick represented CommerceIQ on the deal. CommerceIQ, a retail ecommerce management platform, announced its $115 million Series D financing, bringing its valuation to more than $1 billion....
You must be a Standard 1 Year member to access this content.
Fenwick advised Suplari on the deal while Perkins Coie represented Microsoft Corporation. Microsoft has acquired Suplari, a Seattle startup that uses artificial intelligence to help companies...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Impel NeuroPharma on the deal. Impel NeuroPharma, a late-stage pharmaceutical company developing transformative therapies for diseases of the central nervous system, announced its...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Act-On Software on the deal. Act-On Software, a leading growth marketing automation platform, announced its financing round from existing investors U.S. Venture...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Redfin Corporation on the deal. Redfin Corporation (NASDAQ: RDFN), a technology-powered real estate broker, instant home-buyer, lender, title insurer and renovations...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Icertis on the deal. Icertis, a contract intelligence company that pushes the boundaries of what’s possible with contract lifecycle management, announced its...
You must be a Standard 1 Year member to access this content.
